Scientific Information

Invited Speakers

Massimo Levrero
Professor Levrero is Professor of Medicine at the Sapienza University in Rome, Italy. He has recently joined the Centre de Recherche en Cancérologie de Lyon (CRCL) in Lyon, France, where he leads a Research Unit on ”Epigenetics and Epigenomics of Hepatocellular Carcinoma”, and the Service d’Hepatologie et Gastroenterologie - Hopital de la Croix Rousse - Hospices Civils de Lyon, France, where he continues his academic practice in hepatology. He serves as Associate Member and Director of the Functional Genomics platform at the IIT-Sapienza Center for Life NanoScience (CLNS) in Rome
Italy

Lim Seng Gee
Prof Lim is Director of Hepatology, Dept of Gastroenterology & Hepatology National University Hospital, Chairman of the Singapore Hepatitis Conference, Governing Council Member, International Association for Study of Liver; and Adjunct Principal Investigator, Institute of Molecular and Cell Biology, ASTAR
Singapore

Stephen Locarnini
Prof Locarnini is a Head of Department at Research & Molecular Development, Victorian Infectious Diseases Reference Laboratory, University of Melbourne, WHO Regional Reference Laboratory for Hepatitis B. His research interests include Hepatitis A, B, C, D, E, public health, co-infection with HIV, pathogenesis, cure strategies.
Australia

Peter Revill
Professor Revill is a Senior Medical Scientist at the Victorian Infectious Diseases Reference Laboratory (VIDRL), Section Head of the Molecular Virology Group, Division of Research and Molecular Development and the President of Australasian Centre for Hepatitis Virology.
Australia

Robert Thimme
Prof Thimme is the Director of the Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases). His research focus lies on the immune responses in hepatitis B virus (HBV) and hepatitis C virus (HCV) infection as well as hepatocellular carcinoma (HCC). His main focuses are the immunological determinants of viral clearance and persistence with a special focus on CD8+ T cells.
Germany